We are live on
!
Find out more
TBA
Tower Bridge Advisors Portfolio holdings
AUM
$1.11B
1-Year Est. Return
25.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+25.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+97.78%
10 Year Est. Return
+333.25%
AUM
$825M
AUM Growth
+$3.75M
(+0.46%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
23.21%
Holding
217
New
9
Increased
35
Reduced
117
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$8.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.89M |
| 3 |
Invesco
IVZ
|
+$3.08M |
| 4 |
Digital Realty Trust
DLR
|
+$2.99M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$3.03M |
| 2 |
Caterpillar
CAT
|
+$2.21M |
| 3 |
CVS Health
CVS
|
+$2.2M |
| 4 |
Goldman Sachs
GS
|
+$2.12M |
| 5 |
Colgate-Palmolive
CL
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.38% |
| 2 | Technology | 14.33% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 10.85% |
| 5 | Energy | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Berkshire Hathaway Class A
BRK.A
$1.09T
| $244K | 0.03% |
1
| – | – |
|
177
Healthpeak Properties
DOC
$14B
| $240K | 0.03% |
8,074
-791
| -9% | -$24.1K |
|
178
Gilead Sciences
GILD
$178B
| $235K | 0.03% |
3,276
| – | – |
|
179
Eli Lilly
LLY
$996B
| $228K | 0.03% |
3,101
| – | – |
|
|
CXO
180
DELISTED
CONCHO RESOURCES INC.
CXO
| $228K | 0.03% |
1,720
| – | – |
|
181
Imperial Oil
IMO
$62.5B
| $226K | 0.03% |
6,500
-3,600
| -36% | -$121K |
|
182
Pentair
PNR
$9.1B
| $223K | 0.03% |
5,919
| – | – |
|
183
EQT Corp
EQT
$33.9B
| $222K | 0.03% |
6,246
| – | – |
|
184
Eversource Energy
ES
$25.8B
| $221K | 0.03% |
4,006
| – | – |
|
185
Boston Properties
BXP
$10.3B
| $214K | 0.03% |
1,700
| – | – |
|
186
Vertex Pharmaceuticals
VRTX
$131B
| $214K | 0.03% |
2,900
-700
| -19% | -$57K |
|
187
Yum! Brands
YUM
$38.7B
| $212K | 0.03% |
3,350
-1,310
| -28% | -$82.3K |
|
188
Deere & Co
DE
$183B
| $206K | 0.03% |
+2,000
| New | +$188K |
|
189
EOG Resources
EOG
$77B
| $205K | 0.02% |
+2,026
| New | +$197K |
|
190
Bank of America
BAC
$440B
| – | – |
-10,046
| Closed | -$157K |
|
191
AB InBev
BUD
$154B
| – | – |
-2,800
| Closed | -$368K |
|
192
Consolidated Edison
ED
$39.5B
| – | – |
-7,203
| Closed | -$542K |
|
193
Illumina
ILMN
$31.3B
| – | – |
-1,249
| Closed | -$221K |
|
|
ACH
194
Accendra Health
ACH
$83.1M
| – | – |
-6,000
| Closed | -$208K |
|
|
PNY
195
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| – | – |
-15,500
| Closed | -$931K |
|
Similar funds
GP
TC
GP
MSA
OBWG
AI
HAS
CFO
Tower Bridge Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Tower Bridge Advisors held 217 positions worth $825M, up 0.46% from $821M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Tower Bridge Advisors's Q4 2016 filing shows 9 new, 35 increased, 117 reduced and 7 closed positions. Its largest new stake was Invesco: 100,155 shares worth $3.04M. The largest sale was Novartis, an estimated $3.03M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
- Tower Bridge Advisors's largest Q4 2016 buy was Invesco: 100,155 shares worth $3.04M.
- Tower Bridge Advisors added most to Medtronic in Q4 2016, an estimated $8.4M increase.
- Tower Bridge Advisors's biggest Q4 2016 reduction was Novartis, cutting an estimated $3.03M.
- Tower Bridge Advisors fully exited PIEDMONT NATURAL GAS CO INC(NC in Q4 2016, selling an estimated $931K.
- Tower Bridge Advisors's ten largest holdings make up 23% of its $825M portfolio in Q4 2016.
- Tower Bridge Advisors opened 9 new positions and closed 7 in Q4 2016.
- Tower Bridge Advisors's portfolio value rose 0.46% quarter-over-quarter to $825M.
Based on Tower Bridge Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.